Effects of oral fish oil on choroidal blood flow in adults

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069609

Enrollment

Unknown

Registered

2023-03-21

Start date

2023-04-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fundus disease

Interventions

Intervention group:Oral administration of fish oil

Eligibility

Sex/Gender

All

Age

40 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Age 40-50, gender unlimited; (2) -6.00D=0.8; (3) No fatty acid dietary supplements have been taken in the past 2 weeks.

Exclusion criteria

Exclusion criteria: (1) Eye trauma, surgery or other chronic eye diseases; (2) strabismus; (3) intraocular pressure >=21mmHg, interocular pressure difference >=5mmHg; (4) History of systemic diseases, such as hypertension, diabetes, hyperlipidemia, etc.; (5) Allergic history of taking fish oil products; (6) Other conditions researchers think that it is not suitable to participate in the study.

Design outcomes

Primary

Measure	Time frame
choroidal thickness;choroidal vascularity index;choriocapillaris flow deficits;	—

Countries

China

Contacts

Public ContactHao Wu

Eye Hospital, Wenzhou Medical University

wuhao@mail.eye.ac.cn15958710273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026